Medicare Enrolled

Dr. Jay Lipshitz, MD

Hematology & Oncology · New Hyde Park, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
27005 76TH AVE, New Hyde Park, NY 11040
7184704000
In practice since 2009 (17 years)
NPI: 1134363278 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lipshitz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lipshitz? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lipshitz

Dr. Jay Lipshitz is a hematology & oncology specialist in New Hyde Park, NY, with 17 years of NPI registration. Based on federal Medicare data, Dr. Lipshitz performed 831 Medicare services across 465 unique beneficiaries.

Between the years covered by Open Payments, Dr. Lipshitz received a total of $4,599 from 33 pharmaceutical and/or device companies across 225 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lipshitz is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ Top 47% volume in NY $4,599 industry payments

Medicare Practice Summary

Medicare Utilization ↗
831
Medicare services
Top 47% in NY for hematology & oncology
465
Unique beneficiaries
$75
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~49 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
408 $83 $305
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
232 $51 $204
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
52 $117 $375
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
46 $66 $240
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
40 $117 $429
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
35 $72 $220
Telephone medical discussion, 5-10 minutes
A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters.
18 $30 $129
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,599
Total received (2018-2024)
Avg $657/year across 7 years
Top 36% in NY for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
33
Companies
225
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,599 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,023
2023
$937
2022
$590
2021
$309
2020
$52
2019
$676
2018
$1,012

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Takeda Pharmaceuticals U.S.A., Inc.
$155
Janssen Biotech, Inc.
$131
AstraZeneca Pharmaceuticals LP
$108
Daiichi Sankyo Inc.
$87
Bayer Healthcare Pharmaceuticals Inc.
$72
GENZYME CORPORATION
$71
Novartis Pharmaceuticals Corporation
$57
Celgene Corporation
$53
PFIZER INC.
$50
Agios Pharmaceuticals, Inc.
$45
E.R. Squibb & Sons, L.L.C.
$43
Blueprint Medicines Corporation
$36
Genmab U.S., Inc.
$26
Dendreon Pharmaceuticals LLC
$26
Alexion Pharmaceuticals, Inc.
$24
Eisai Inc.
$22
Astellas Pharma US Inc
$18
Top 3 companies account for 38.6% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$698
Janssen Biotech, Inc.
$454
E.R. Squibb & Sons, L.L.C.
$339
PFIZER INC.
$315
Merck Sharp & Dohme LLC
$279
Takeda Pharmaceuticals U.S.A., Inc.
$254
Celgene Corporation
$220
AstraZeneca Pharmaceuticals LP
$182
Daiichi Sankyo Inc.
$162
Lilly USA, LLC
$160
Bayer HealthCare Pharmaceuticals Inc.
$160
Merck Sharp & Dohme Corporation
$141
Eisai Inc.
$107
GENZYME CORPORATION
$106
Bayer Healthcare Pharmaceuticals Inc.
$91
Gilead Sciences, Inc.
$89
Exelixis Inc.
$88
Rigel Pharmaceuticals, Inc.
$86
TerSera Therapeutics LLC
$85
Astellas Pharma US Inc
$72
Seattle Genetics, Inc.
$61
TESARO, Inc.
$58
Amgen Inc.
$55
Incyte Corporation
$49
Agios Pharmaceuticals, Inc.
$45
Shire North American Group Inc
$39
Taiho Oncology, Inc.
$37
Blueprint Medicines Corporation
$36
Genentech USA, Inc.
$34
Genmab U.S., Inc.
$26
Dendreon Pharmaceuticals LLC
$26
Alexion Pharmaceuticals, Inc.
$24
Myovant Sciences Inc.
$22
Top 3 companies account for 32.4% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · AYVAKIT · CALQUENCE · CYRAMZA · Cabometyx · DARZALEX · ELIQUIS · ERLEADA · Enhertu · Epkinly · FASLODEX · GAZYVA · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · JAKAFI · KEYTRUDA · KISQALI · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MYLOTARG · NINLARO · Neulasta · Nplate · ONCASPAR · ONUREG · OPDIVO · ORGOVYX · OXBRYTA · PIQRAY · PROMACTA · PROVENGE · PYRUKYND · REBLOZYL · REMICADE · RYDAPT · Rezlidhia · SANDOSTATIN · SARCLISA · SCEMBLIX · SUTENT · Stivarga · TASIGNA · TECVAYLI · Tavalisse · ULTOMIRIS · VARUBI · VERZENIO · VOTRIENT · VPRIV · Vyloy · XOSPATA · XTANDI · Xofigo · ZEJULA · ZOLADEX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a hematology & oncology specialist in New Hyde Park?
Compare hematology & oncology specialists in the New Hyde Park area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
670
Per 100K population
48.3
County median income
$143,408
Nearest hospital
LONG ISLAND JEWISH MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Lipshitz is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Lipshitz experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Lipshitz performed 408 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lipshitz receive payments from pharmaceutical companies?
Yes. Dr. Lipshitz received a total of $4,599 from 33 companies across 225 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lipshitz's costs compare to other hematology & oncology specialists in New Hyde Park?
Dr. Lipshitz's average Medicare payment per service is $75. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lipshitz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →